MaineHealth picks a high-profile physician CIO to lead its IT department
MaineHealth, northern New England’s largest health system, has selected a physician-information technology leader from Boston Children’s Hospital to lead its
Role of gut viruses in inflammatory bowel disease is focus of $8.5 million grant
The communities of bacteria that live in our digestive tracts help digest food and produce vitamins, protect against pathogens, and
The New TikTok ‘Benadryl Challenge' is Being Blamed for a Teenage Girl’s Death—Here's Why It's So Dangerous
TikTok challenges—and before the app, challenges done by teenagers in general—aren't anything new. Since the pandemic started, they've largely focused
The Next Generation! Nicki Minaj and Drake's Sons Will Have Playdates 'Soon'
BFFs! Nicki Minaj wants her baby boy to hang out with Drake’s 3-year-old son, Adonis. Pregnancy Pics! See Nicki Minaj’s
Follow These 5 Steps & Get Yourself Killer Six Pack Abs
Every bоdуbuildеr aims for ripped аbѕ, considering they’re thе hallmark of having a Godly body. Nоt mаnу оf uѕ wеrе
RedHill Biopharma Announces FDA Orphan Drug Designation for RHB-204 for the Treatment of NTM Infections
TEL AVIV, Israel and RALEIGH, NC, October 14, 2020, RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today
![U.S. Food and Drug Administration Approves Haegarda (C1 Esterase Inhibitor Subcutaneous [Human]) for Prevention of Hereditary Angioedema (HAE) Attacks in Pediatric Patients](https://tgihealthcareerp.com/wp-content/uploads/sites/28/2018/12/NjHM5GAIBkRRZatXItDi.jpg "U.S. Food and Drug Administration Approves Haegarda (C1 Esterase Inhibitor Subcutaneous [Human]) for Prevention of Hereditary Angioedema (HAE) Attacks in Pediatric Patients")
How Kris Jenner Built a Beauty Empire
These days, Kris Jenner is thinking outside of the box. Literally. It’s just days after she has announced the end
